Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Rituximab Combining Bortezomib Versus Rituximab in Management of ITP

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03443570
Recruitment Status : Not yet recruiting
First Posted : February 23, 2018
Last Update Posted : February 23, 2018
Sponsor:
Collaborators:
The Affiliated Hospital of Qingdao University
Yantai Yuhuangding Hospital
Information provided by (Responsible Party):
Ming Hou, Shandong University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : March 1, 2020
Estimated Study Completion Date : March 1, 2021